Axelyf
Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
$2.6M Seed ·
Source: startupintros.com
Latest round on record: Seed, October 2026, amount undisclosed.
All 2 rounds ↓About Axelyf
Axelyf is a company based in Brookline, United States. Recent Funding lists it under Health and bio (also Logistics and mobility). It raised $2.6M in a Seed round in August 2025, according to startupintros.com. Its latest round on record is a Seed round in October 2026, amount undisclosed. Investors on record include Brunnur Ventures, Omega ehf and Silfurberg. It was founded by John Lucas and Örn Almarsson.
Funding rounds
- Seed · amount undisclosedSource: sec.gov
- Seed · $2.6MSource: startupintros.com
- Website created
Founders and team
JL
John Lucas FounderÖA
Örn Almarsson Founder- DFDaniel Frímannsson Head of Nucleic Acid Technologies & Biology
Investors
Similar Health and bio companies
HHexagon Bio$62M Series B+ · Oct 2026
HHeyVoli$500K Pre Seed · Oct 2026
VVitalls$1.5M Seed · Oct 2026WWarp Sciences$215M Series A · Oct 2026
PPAM2L Biotechnologies$29.97M Series A · Oct 2026
CCureBay$10.55M Series B+ · Oct 2026
Questions and sources
Axelyf: questions and answers
- How much has Axelyf raised?
- Axelyf has raised $2.6M in one sourced round on record (Seed), announced August 29, 2025.
- Who invested in Axelyf?
- Investors on record for Axelyf: Brunnur Ventures, Omega ehf and Silfurberg.
- Who founded Axelyf?
- Axelyf was founded by John Lucas and Örn Almarsson.
- Where is Axelyf based?
- Axelyf is based in Brookline, United States.
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/axelyf (get a free API key).